Cargando…
COVID-19 Vaccination in Patients with Myasthenia Gravis: A Single-Center Case Series
In this study, we report the safety of coronavirus disease 2019 (COVID-19) vaccine in patients with myasthenia gravis (MG). Patients who were vaccinated against COVID-19 were included. Demographics, clinical characteristics, medications, and vaccination information were collected. The main observati...
Autores principales: | Ruan, Zhe, Tang, Yonglan, Li, Chunhong, Sun, Chao, Zhu, Ying, Li, Zhuyi, Chang, Ting |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8537454/ https://www.ncbi.nlm.nih.gov/pubmed/34696220 http://dx.doi.org/10.3390/vaccines9101112 |
Ejemplares similares
-
Knowledge mapping of targeted immunotherapy for myasthenia gravis from 1998 to 2022: A bibliometric analysis
por: Su, Yue, et al.
Publicado: (2022) -
Development and Validation of a Nomogram for Predicting Generalization in Patients With Ocular Myasthenia Gravis
por: Ruan, Zhe, et al.
Publicado: (2022) -
Landscape analysis of m6A modification regulators related biological functions and immune characteristics in myasthenia gravis
por: Li, Shuang, et al.
Publicado: (2023) -
Melatonin exerts immunoregulatory effects by balancing peripheral effector and regulatory T helper cells in myasthenia gravis
por: Chang, Ting, et al.
Publicado: (2020) -
Regulatory B Cells Are Decreased and Functionally Impaired in Myasthenia Gravis Patients
por: Lin, Ye, et al.
Publicado: (2022)